US Sanofi-Aventis precedent adds to toolbox for patentee prosecution and litigation success

The ruling by the US Court of Appeals for the Federal Circuit limits analogous art, and innovators can leverage this precedent by adopting certain patent drafting methods

Unlock unlimited access to all IAM content